AstraZeneca could become the first company to bring an oral selective oestrogen receptor degrader (SERD) drug to market as a ...

Application error: a client-side exception has occurred (see the browser console for more information).

A new research paper was published in , Volume 16, on February 18, 2025, titled "Leukopenia, weight loss and oral mucositis induced by 5-Fluorouracil in hamsters' model: A regenerative approach using ...

When people undergo radiotherapy for cancer, it's not just the tumor that suffers. The radiation causes DNA breaks in healthy ...

RedHill has signed an exclusive licensing agreement with Hyloris for the global development and commercialisation of RHB-102 ...

Scarlett, a retired thoroughbred racehorse and descendant of Secretariat, has become like family for Jenna and her parents, Kim and Matt.

About 60% of all cancer patients in the United States receive radiation therapy as part of their treatment. However, this ...

Tardigrades, microscopic organisms renowned for their extraordinary resistance to radiation, may offer a means to protect ...

The FDA has granted AUTX-703, a first-in-class oral KAT2A/B degrader, fast track designation for the treatment of ...

This is just one of many congenital diseases that can affect pets. Congenital diseases are disorders or abnormalities that ...

The FDA accepted for priority review a supplemental Biologics License Application for Keytruda for resectable locally ...